Clinical application of immunomagnetic reduction for quantitative analysis of beta-subunit of human chorionic gonadotropin in blastocyst culture media to differentiate embryo quality

Written By Yiran Gan
Clinical application of immunomagnetic reduction for quantitative analysis of beta-subunit of human chorionic gonadotropin in blastocyst culture media to differentiate embryo quality - Chen et al. 2019

Clinical application of immunomagnetic reduction for quantitative analysis of beta-subunit of human chorionic gonadotropin in blastocyst culture media to differentiate embryo quality

Publication Date: 2019.01.25

Authors: Chen CY, Hwu YM, Weng YW, Lu CH, Chen YJ, Sun FJ

Journal: Clin Chim Acta. 2019 Jan 16. pii: S0009-8981(19)30025-7

DOI: 10.1016/j.cca.2019.01.012

Citation

Chen CY, Hwu YM, Weng YW, Lu CH, Chen YJ, Sun FJ. "Clinical application of immunomagnetic reduction for quantitative analysis of beta-subunit of human chorionic gonadotropin in blastocyst culture media to differentiate embryo quality". Clin Chim Acta. 2019 Jan 16. pii: S0009-8981(19)30025-7. doi: 10.1016/j.cca.2019.01.012

Article Link

https://www.sciencedirect.com/science/article/pii/S0009898119300257?via%3Dihub

© 2019 Chen, Hwu, Weng, Lu, Chen, and Sun

Clinica Chimica Acta

Yiran Gan
Previous

Long-Term Storage Effects on Stability of Aβ1–40, Aβ1–42, and Total Tau Proteins in Human Plasma Samples Measured with Immunomagnetic Reduction Assays
Next

Precision Medicine: Role of Biomarkers in Early Prediction and Diagnosis of Alzheimer’s Disease